Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Baptiste Latouche

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Bulletin Du Cancer|March 19, 2013
[Immune response and colorectal cancer]David Tougeron, Emilie Fauquembergue, Jean-Baptiste Latouche
Oncoimmunology|July 29, 2016
Frameshift mutations, neoantigens and tumor-specific CD8(+) T cells in microsatellite unstable colorectal cancersPauline Maby, Jérôme Galon, Jean-Baptiste Latouche
Bulletin Du Cancer|August 7, 2013
[Immunotherapy for colorectal cancer]David Tougeron, Émilie Fauquembergue, Jean-Baptiste Latouche
Cancer Research|June 17, 2005
Artificial antigen-presenting cells transduced with telomerase efficiently expand epitope-specific, human leukocyte antigen-restricted cytotoxic T cellsJakob Dupont, Jean-Baptiste Latouche, Chia Ma, et al.
Nature Biotechnology|April 3, 2004
The ABCs of artificial antigen presentationJiyun V Kim, Jean-Baptiste Latouche, Isabelle Rivière, et al.
Leukemia Research|June 27, 2017
Heterogeneous epigenetic regulation of HACE1 in Burkitt- Lymphoma-derived cellsAbdelilah Bouzelfen, Hafid Kora, Marion Alcantara, et al.
Blood|June 14, 2003
Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA alleleGenovefa A Papanicolaou, Jean-Baptiste Latouche, Cuiwen Tan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2005
Langerhans cells derived from genetically modified human CD34+ hemopoietic progenitors are more potent than peptide-pulsed Langerhans cells for inducing antigen-specific CD8+ cytolytic T lymphocyte responsesJianda Yuan, Jean-Baptiste Latouche, John L Reagan, et al.
Frontiers in Immunology|June 4, 2019
HLA-Class II Artificial Antigen Presenting Cells in CD4<sup>+</sup> T Cell-Based ImmunotherapyAlexandre Couture, Anthony Garnier, Fabian Docagne, et al.
Human Genetics|October 22, 2008
Gradual reduction of BUBR1 protein levels results in premature sister-chromatid separation then in aneuploidyElodie Bohers, Nasrin Sarafan-Vasseur, Aurélie Drouet, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Bulletin Du Cancer|March 19, 2013
[Immune response and colorectal cancer]David Tougeron, Emilie Fauquembergue, Jean-Baptiste Latouche
Oncoimmunology|July 29, 2016
Frameshift mutations, neoantigens and tumor-specific CD8(+) T cells in microsatellite unstable colorectal cancersPauline Maby, Jérôme Galon, Jean-Baptiste Latouche
Bulletin Du Cancer|August 7, 2013
[Immunotherapy for colorectal cancer]David Tougeron, Émilie Fauquembergue, Jean-Baptiste Latouche
Cancer Research|June 17, 2005
Artificial antigen-presenting cells transduced with telomerase efficiently expand epitope-specific, human leukocyte antigen-restricted cytotoxic T cellsJakob Dupont, Jean-Baptiste Latouche, Chia Ma, et al.
Nature Biotechnology|April 3, 2004
The ABCs of artificial antigen presentationJiyun V Kim, Jean-Baptiste Latouche, Isabelle Rivière, et al.
Leukemia Research|June 27, 2017
Heterogeneous epigenetic regulation of HACE1 in Burkitt- Lymphoma-derived cellsAbdelilah Bouzelfen, Hafid Kora, Marion Alcantara, et al.
Blood|June 14, 2003
Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA alleleGenovefa A Papanicolaou, Jean-Baptiste Latouche, Cuiwen Tan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2005
Langerhans cells derived from genetically modified human CD34+ hemopoietic progenitors are more potent than peptide-pulsed Langerhans cells for inducing antigen-specific CD8+ cytolytic T lymphocyte responsesJianda Yuan, Jean-Baptiste Latouche, John L Reagan, et al.
Frontiers in Immunology|June 4, 2019
HLA-Class II Artificial Antigen Presenting Cells in CD4<sup>+</sup> T Cell-Based ImmunotherapyAlexandre Couture, Anthony Garnier, Fabian Docagne, et al.
Human Genetics|October 22, 2008
Gradual reduction of BUBR1 protein levels results in premature sister-chromatid separation then in aneuploidyElodie Bohers, Nasrin Sarafan-Vasseur, Aurélie Drouet, et al.
Pageof 4